Standard BioTools Adopts 2024 Change of Control and Severance Plan for Key Executives

STANDARD BIOTOOLS INC.

Plan provides 12 months base salary and full equity vesting for non-COC termination for COO Kim, CLO Gallagher, CCO Davis, and others.
For termination during Change of Control Period: 150% lump-sum of base salary plus bonus, 18-month COBRA, and immediate full equity vesting.
Plan supersedes the 2023 severance plan and covers eight named executives including SVP King, SVP Abou-Sayed, and CHRO Jensen.
Plan term runs until August 4, 2026; CEO Michael Egholm remains covered under separate 2023 plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.